<!DOCTYPE html> <html lang="en"> <head> <meta http-equiv="Content-Type" content="text/html; charset=UTF-8"> <meta name="google-site-verification" content="luAbE4CdIEUnJrEZtEF-1OX-Dg7IMVEMi_czr5GT4sk"> <meta charset="utf-8"> <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"> <meta http-equiv="X-UA-Compatible" content="IE=edge"> <title> Chang Jie Mick Lee, Ph.D </title> <meta name="author" content="Chang Jie Mick Lee, Ph.D"> <meta name="description" content="A simple, whitespace theme for academics. Based on [*folio](https://github.com/bogoli/-folio) design. "> <link rel="stylesheet" href="/assets/css/bootstrap.min.css?a4b3f509e79c54a512b890d73235ef04"> <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/mdbootstrap@4.20.0/css/mdb.min.css" integrity="sha256-jpjYvU3G3N6nrrBwXJoVEYI/0zw8htfFnhT9ljN3JJw=" crossorigin="anonymous"> <link defer rel="stylesheet" href="/assets/css/academicons.min.css?f0b7046b84e425c55f3463ac249818f5"> <link defer rel="stylesheet" type="text/css" href="https://fonts.googleapis.com/css?family=Roboto:300,400,500,700|Roboto+Slab:100,300,400,500,700|Material+Icons&amp;display=swap"> <link defer rel="stylesheet" href="/assets/css/jekyll-pygments-themes-github.css?591dab5a4e56573bf4ef7fd332894c99" media="" id="highlight_theme_light"> <link rel="shortcut icon" href="data:image/svg+xml,&lt;svg%20xmlns=%22http://www.w3.org/2000/svg%22%20viewBox=%220%200%20100%20100%22&gt;&lt;text%20y=%22.9em%22%20font-size=%2290%22&gt;%E2%9A%9B%EF%B8%8F&lt;/text&gt;&lt;/svg&gt;"> <link rel="stylesheet" href="/assets/css/main.css?d41d8cd98f00b204e9800998ecf8427e"> <link rel="canonical" href="https://cjmlee.github.io/"> <link defer rel="stylesheet" href="/assets/css/jekyll-pygments-themes-native.css?5847e5ed4a4568527aa6cfab446049ca" media="none" id="highlight_theme_dark"> <script src="/assets/js/theme.js?0afe9f0ae161375728f7bcc5eb5b4ab4"></script> </head> <body class="fixed-top-nav "> <header> <nav id="navbar" class="navbar navbar-light navbar-expand-sm fixed-top" role="navigation"> <div class="container"> <button class="navbar-toggler collapsed ml-auto" type="button" data-toggle="collapse" data-target="#navbarNav" aria-controls="navbarNav" aria-expanded="false" aria-label="Toggle navigation"> <span class="sr-only">Toggle navigation</span> <span class="icon-bar top-bar"></span> <span class="icon-bar middle-bar"></span> <span class="icon-bar bottom-bar"></span> </button> <div class="collapse navbar-collapse text-right" id="navbarNav"> <ul class="navbar-nav ml-auto flex-nowrap"> <li class="nav-item active"> <a class="nav-link" href="/">about <span class="sr-only">(current)</span> </a> </li> <li class="nav-item "> <a class="nav-link" href="/publications/">publications </a> </li> <li class="nav-item "> <a class="nav-link" href="/repositories/">Repositories </a> </li> <li class="toggle-container"> <button id="light-toggle" title="Change theme"> <i class="fa-solid fa-moon"></i> <i class="fa-solid fa-sun"></i> </button> </li> </ul> </div> </div> </nav> <progress id="progress" value="0"> <div class="progress-container"> <span class="progress-bar"></span> </div> </progress> </header> <div class="container mt-5" role="main"> <div class="post"> <header class="post-header"> <h1 class="post-title"> <span class="font-weight-bold">Chang Jie Mick</span> Lee, Ph.D </h1> <p class="desc">Post-doctoral Scientist, National University of Singapore</p> </header> <article> <div class="profile float-right"> <figure> <picture> <img src="/assets/img/MickLee_Head.jpg?06e731f6aae579615903d144f91762e1" class="img-fluid z-depth-1 rounded" width="100%" height="auto" alt="MickLee_Head.jpg" onerror="this.onerror=null; $('.responsive-img-srcset').remove();"> </picture> </figure> <div class="more-info"> <p>Present Address: </p> <p>14 Medical Drive </p> <p>Cardiovascular Research Institute, Building MD6</p> <p>Singapore, 117599</p> </div> </div> <div class="clearfix"> <p>Mick is a Stem Cell and computational biologist based in Roger Fooâ€™s Group at the Cardiovascular Research Institute, National University of Singapore Yong Loo Lin School of Medicine. He obtain his bachelors and PhD here in Singapore at NUS and the Genome Institute of Singapore. He use functional genomics such as CRISPR screens and gene editing tools for application in 2D and 3D human stem-cell derived models, and building multi-modal reporter systems to study cardiac cell fate, gene regulation, disease and regeneration. On the computational side, he focused on understanding the cardiac regulome which include the integrative analysis and processing of multi-omics and disease GWAS datasets. He is excited about gene editing approaches and the application of stem cell research to treat cardiovascular diseases</p> </div> <h2> <a href="/news/" style="color: inherit">news</a> </h2> <div class="news"> <div class="table-responsive" style="max-height: 60vw"> <table class="table table-sm table-borderless"> <tr> <th scope="row" style="width: 20%">May 14, 2025</th> <td> Pleased to share our recent contribution to a compendium on Interorgan Crosstalk in Heart Failure and Cardiometabolic Disease, now published in Circulation Research. We teamed up with clinical trialists and multidisciplinary experts to examine the evolving landscape of interorgan communication in heart failure, with a focus on the cardio-kidney-liver-metabolic axis. This topic is particularly relevant to us in Singapore, where cardiovascular and metabolic diseases are highly prevalent and intersecting in complex ways. Grateful to our collaborators and the editors for the opportunity to be part of this important effort ! ðŸ”— Read our article: https://lnkd.in/gCzPjQ92 ðŸ“š Full compendium: https://lnkd.in/geujrqWt </td> </tr> <tr> <th scope="row" style="width: 20%">May 14, 2025</th> <td> Pleased to share our collaborative research, now published in Nature Cardiovascular Research led by Nilanjana Sadhu and the folks at Nanyang Technological University Singapore. Using safe-harbor hESCs, we leveraged on robust genetic and metabolic evidence from Asian cohorts to engineer overexpression and loss-of-function hESC stable cell lines, validating the causality of FDX1 and 3BH5C. Read it here: https://www.nature.com/articles/s44161-025-00638-w PMID: 40360795 </td> </tr> <tr> <th scope="row" style="width: 20%">May 14, 2025</th> <td> Speaking at the International Society for Heart Research (ISHR) World Congress ! and Hosting the ECI Symposium and Panel discussions. Fellow ECIs fall in ! For more details: https://www.ishr2025nara.jp/ </td> </tr> <tr> <th scope="row" style="width: 20%">Jul 05, 2024</th> <td> Published Editorial on the role of TRIM35 in p53-induced Heart Failure Pathogenesis in Circ Research. DOI: 10.1161/CIRCRESAHA.124.324792 PMID: 38963873 </td> </tr> <tr> <th scope="row" style="width: 20%">May 17, 2024</th> <td> Our Manuscript on adherens junction and hippo-yap signaling regulation on cardiomyocyte differentiation is now published in Circulation! doi: 10.1161/CIRCULATIONAHA.122.061335 PMID: 38752370 </td> </tr> </table> </div> </div> <h2> <a href="/publications/" style="color: inherit">selected publications</a> </h2> <div class="publications"> <ol class="bibliography"> <li> <div class="row"> <div id="RN1" class="col-sm-10"> <div class="title">Assigning Distal Genomic Enhancers to Cardiac Disease-Causing Genes</div> <div class="author"> *C. G. Anene-Nzelu ,Â  *W. L. W. Tan ,Â  <u><b>*C. J. M. Lee</b></u> ,Â  Z. Wenhao ,Â  A. Perrin ,Â  A. Dashi ,Â  Z. Tiang ,Â  M. I. Autio ,Â  B. Lim ,Â  E. Wong ,Â  H. S. Tan ,Â  B. Pan ,Â  M. P. Morley ,Â  K. B. Margulies ,Â  T. P. Cappola ,Â  andÂ  R. S. Foo </div> <div class="periodical"> 2020 </div> <div class="periodical"> 1524-4539 R01 HL105993/HL/NHLBI NIH HHS/United States Letter United States 2020/09/01 Circulation. 2020 Sep;142(9):910-912. doi: 10.1161/CIRCULATIONAHA.120.046040. Epub 2020 Aug 31. </div> <div class="links"> <a href="https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.046040" class="btn btn-sm z-depth-0" role="button" rel="external nofollow noopener" target="_blank">HTML</a> </div> <div class="badges"> <span class="__dimensions_badge_embed__" data-doi="https://doi.org/10.1161/CIRCULATIONAHA.120.046040" data-hide-zero-citations="true" data-style="small_rectangle" data-legend="hover-right" style="margin-bottom: 3px;"></span> </div> </div> </div> </li> <li> <div class="row"> <div id="RN4" class="col-sm-10"> <div class="title">Genomic enhancers in cardiac development and disease</div> <div class="author"> C. G. Anene-Nzelu ,Â  <u><b>C. J. M. Lee</b></u> ,Â  W. L. W. Tan ,Â  A. Dashi ,Â  andÂ  R. S. Y. Foo </div> <div class="periodical"> 2022 </div> <div class="periodical"> Anene-Nzelu, Chukwuemeka G Lee, Mick C J Tan, Wilson L W Dashi, Albert Foo, Roger S Y eng Review England 2021/08/13 Nat Rev Cardiol. 2022 Jan;19(1):7-25. doi: 10.1038/s41569-021-00597-2. Epub 2021 Aug 11. </div> <div class="links"> <a class="abstract btn btn-sm z-depth-0" role="button">Abs</a> </div> <div class="abstract hidden"> <p>The Human Genome Project marked a major milestone in the scientific community as it unravelled the Â 3 billion bases that are central to crucial aspects of human life. Despite this achievement, it only scratched the surface of understanding how each nucleotide matters, both individually and as part of a larger unit. Beyond the coding genome, which comprises only Â 2% of the whole genome, scientists have realized that large portions of the genome, not known to code for any protein, were crucial for regulating the coding genes. These large portions of the genome comprise the â€™non-coding genomeâ€™. The history of gene regulation mediated by proteins that bind to the regulatory non-coding genome dates back many decades to the 1960s. However, the original definition of â€™enhancersâ€™ was first used in the early 1980s. In this Review, we summarize benchmark studies that have mapped the role of cardiac enhancers in disease and development. We highlight instances in which enhancer-localized genetic variants explain the missing link to cardiac pathogenesis. Finally, we inspire readers to consider the next phase of exploring enhancer-based gene therapy for cardiovascular disease.</p> </div> </div> </div> </li> <li> <div class="row"> <div id="Lee2022.11.04.515249" class="col-sm-10"> <div class="title">CTCF mediates the Activity-by-contact derived cis-regulatory hubs</div> <div class="author"> <u><b>C. J. M. Lee</b></u> ,Â  LoÄ±Ìˆc Mangnier ,Â  Cory C. Padilla ,Â  Dominic Paul Lee ,Â  Wilson Tan ,Â  Peter Yiqing Li ,Â  Wen Hao Zheng ,Â  Louis Gan ,Â  Ching Kit Chen ,Â  Yee Phong Lim ,Â  Rina Miao Qin Wang ,Â  Steve Bilodeau ,Â  Alexandre Bureau ,Â  Roger Sik-Yin Foo^ ,Â  andÂ  Chukwuemeka George Anene-Nzelu^ </div> <div class="periodical"> <em>bioRxiv</em>, 2022 </div> <div class="periodical"> </div> <div class="links"> <a class="abstract btn btn-sm z-depth-0" role="button">Abs</a> </div> <div class="abstract hidden"> <p>The 3D chromatin architecture establishes a complex network of genes and regulatory elements necessary for transcriptomic regulation in development and disease. This network can be modeled by cis-regulatory hubs (CRH) which underscore the local functional interactions between enhancers and promoter regions and differ from other higher order chromatin structures such as topological associated domains (TAD). The Activity-by-contact (ABC) model of enhancer-promoter regulation has been recently used in the identification of these CRHs, but little is known about the role of CTCF on the ABC scores and the consequent impact on CRHs. Here we show that the loss of CTCF leads to a reorganization of the enhancer-promoter interactions resulting in a re-distribution of ABC scores of the putative enhancers in C57/bl6 mouse hearts. The loss of CTCF also leads to a global reduction of the total number of CRHs, and an increase in the size of the CRHs due to increase in the number of elements within each hub. In addition, CTCF loss led to more CRHs that cross TAD boundaries. These results provide another layer of evidence to support the importance of CTCF in the formation of regulatory networks necessary for gene regulation.Competing Interest StatementThe authors have declared no competing interest.ChIP-seqChromatin immunoprecipitation with sequencingATAC-seqAssay for Transposase Accessible Chromatin with sequencingHi-CHigh throughput chromatin conformation capture with sequencingABCActivity by contact algorithm</p> </div> </div> </div> </li> <li> <div class="row"> <div id="RN26" class="col-sm-10"> <div class="title">Genome-Wide CRISPR Screen Identifies an NF2-Adherens Junction Mechanistic Dependency for Cardiac Lineage</div> <div class="author"> <u><b>C. J. M. Lee</b></u> ,Â  M. I. Autio ,Â  W. H. Zheng ,Â  Y. Song ,Â  S. C. Wang ,Â  D. C. P. Wong ,Â  J. Xiao ,Â  Y. Zhu ,Â  P. Yusoff ,Â  X. Yei ,Â  W. K. Chock ,Â  B. C. Low ,Â  M. Sudol ,Â  andÂ  R. S. Foo </div> <div class="periodical"> 2024 </div> <div class="periodical"> Lee, Chang Jie Mick Autio, Matias I Zheng, Wen Hao Song, Yoohyun Wang, Shyi Chyi Wong, Darren Chen Pei Xiao, Jingwei Zhu, Yike Yusoff, Permeen Yei, Xi Chock, Wan Kee Low, Boon Chuan Sudol, Marius Foo, Roger S-Y eng 2024/05/16 Circulation. 2024 May 16. doi: 10.1161/CIRCULATIONAHA.122.061335. </div> <div class="links"> <a class="abstract btn btn-sm z-depth-0" role="button">Abs</a> </div> <div class="abstract hidden"> <p>BACKGROUND: Cardiomyocyte differentiation involves a stepwise clearance of repressors and fate-restricting regulators through the modulation of BMP (bone morphogenic protein)/Wnt-signaling pathways. However, the mechanisms and how regulatory roadblocks are removed with specific developmental signaling pathways remain unclear. METHODS: We conducted a genome-wide CRISPR screen to uncover essential regulators of cardiomyocyte specification in human embryonic stem cells using a myosin heavy chain 6 (MYH6)-GFP (green fluorescence protein) reporter system. After an independent secondary sgRNA validation of 25 candidates, we identified NF2 (neurofibromin 2), a moesin-ezrin-radixin like (MERLIN) tumor suppressor, as an upstream driver of early cardiomyocyte lineage specification. Independent monoclonal NF2 knockouts were generated using CRISPR-Cas9, and cell states were inferred through bulk RNA sequencing and protein expression analysis across differentiation time points. Terminal lineage differentiation was assessed by using an in vitro 2-dimensional-micropatterned gastruloid model, trilineage differentiation, and cardiomyocyte differentiation. Protein interaction and post-translation modification of NF2 with its interacting partners were assessed using site-directed mutagenesis, coimmunoprecipitation, and proximity ligation assays. RESULTS: Transcriptional regulation and trajectory inference from NF2-null cells reveal the loss of cardiomyocyte identity and the acquisition of nonmesodermal identity. Sustained elevation of early mesoderm lineage repressor SOX2 and upregulation of late anticardiac regulators CDX2 and MSX1 in NF2 knockout cells reflect a necessary role for NF2 in removing regulatory roadblocks. Furthermore, we found that NF2 and AMOT (angiomotin) cooperatively bind to YAP (yes-associated protein) during mesendoderm formation, thereby preventing YAP activation, independent of canonical MST (mammalian sterile 20-like serine-threonine protein kinase)-LATS (large tumor suppressor serine-threonine protein kinase) signaling. Mechanistically, cardiomyocyte lineage identity was rescued by wild-type and NF2 serine-518 phosphomutants, but not NF2 FERM (ezrin-radixin-meosin homology protein) domain blue-box mutants, demonstrating that the critical FERM domain-dependent formation of the AMOT-NF2-YAP scaffold complex at the adherens junction is required for early cardiomyocyte lineage differentiation. CONCLUSIONS: These results provide mechanistic insight into the essential role of NF2 during early epithelial-mesenchymal transition by sequestering the repressive effect of YAP and relieving regulatory roadblocks en route to cardiomyocytes.</p> </div> </div> </div> </li> <li> <div class="row"> <div id="RN11" class="col-sm-10"> <div class="title">TRIM35: A Proposed Gateway to p53-Induced Heart Failure Pathogenesis</div> <div class="author"> <u><b>C. J. M. Lee</b></u> ,Â  andÂ  R. S. Foo </div> <div class="periodical"> 2024 </div> <div class="periodical"> Lee, Chang Jie Mick Foo, Roger S-Y eng Comment Editorial 2024/07/04 Circ Res. 2024 Jul 5;135(2):314-316. doi: 10.1161/CIRCRESAHA.124.324792. Epub 2024 Jul 4. </div> <div class="links"> </div> </div> </div> </li> <li> <div class="row"> <div id="RN24" class="col-sm-10"> <div class="title">Cardiovascular, Kidney, Liver, and Metabolic Interactions in Heart Failure: Breaking Down Silos</div> <div class="author"> <u><b>C. J. M. Lee</b></u> ,Â  L. B. Kosyakovsky ,Â  M. S. Khan ,Â  F. Wu ,Â  G. Chen ,Â  J. A. Hill ,Â  J. E. Ho ,Â  R. S. Foo ,Â  andÂ  F. Zannad </div> <div class="periodical"> 2025 </div> <div class="periodical"> Lee, Chang Jie Mick Kosyakovsky, Leah B Khan, Muhammad Shahzeb Wu, Feng Chen, Guo Hill, Joseph A Ho, Jennifer E Foo, Roger S-Y Zannad, Faiez eng Review 2025/05/22 Circ Res. 2025 May 23;136(11):1170-1207. doi: 10.1161/CIRCRESAHA.125.325602. Epub 2025 May 22. </div> <div class="links"> <a class="abstract btn btn-sm z-depth-0" role="button">Abs</a> </div> <div class="abstract hidden"> <p>Over the past few decades, the rising burden of metabolic disease, including type 2 diabetes, prediabetes, obesity, and metabolic dysfunction-associated steatotic liver disease, has corresponded with fundamental shifts in the landscape of heart failure (HF) epidemiology, including the rising prevalence of HF with preserved ejection fraction. It has become increasingly important to understand the role of extracardiac contributors and interorgan communication in the pathophysiology and phenotypic heterogeneity of HF. Whereas traditional epidemiological strategies have separately examined individual contributions of specific comorbidities to HF risk, these approaches may not capture the shared mechanisms and more complex, bidirectional relationships between cardiac and noncardiac comorbidities. In this review, we highlight the cardiac, kidney, liver, and metabolism multiorgan interactions and pathways that complicate HF development and progression and propose research strategies to further understand HF in the context of multiple organ disease. This includes evolving epidemiological approaches such as multiomics and machine learning which may better capture common underlying mechanisms and interorgan crosstalk. We review existing preclinical models of HF and how they have enhanced our understanding of the role of multiorgan disease in the development of HF subtypes. We suggest recommendations as to how clinical practice across multiple specialties should screen for and manage multiorgan involvement in HF. Finally, recognizing the advent of novel combinatorial therapeutic agents that may have multiple indications across the cardiac-kidney-liver metabolism continuum, we review the current clinical trials landscape. We specifically highlight a pressing need for the design of more inclusive trials that examine the contributions of multimorbidity and incorporate multiorgan end points, which we propose may lead to outcomes that are evermore clinically relevant today.</p> </div> </div> </div> </li> </ol> </div> <div class="social"> <div class="contact-icons"> <a href="mailto:%6D%69%63%6B.%6C%65%65@%75.%6E%75%73.%65%64%75" title="email"><i class="fa-solid fa-envelope"></i></a> <a href="https://orcid.org/0000-0001-6673-9391" title="ORCID" rel="external nofollow noopener" target="_blank"><i class="ai ai-orcid"></i></a> <a href="https://github.com/cjmlee" title="GitHub" rel="external nofollow noopener" target="_blank"><i class="fa-brands fa-github"></i></a> <a href="https://www.linkedin.com/in/cjmlee" title="LinkedIn" rel="external nofollow noopener" target="_blank"><i class="fa-brands fa-linkedin"></i></a> <a href="https://twitter.com/meekelee" title="X" rel="external nofollow noopener" target="_blank"><i class="fa-brands fa-x-twitter"></i></a> <a href="https://gitlab.com/cjmlee" title="GitLab" rel="external nofollow noopener" target="_blank"><i class="fa-brands fa-gitlab"></i></a> <a href="/feed.xml" title="RSS Feed"><i class="fa-solid fa-square-rss"></i></a> </div> <div class="contact-note"></div> </div> </article> </div> </div> <footer class="fixed-bottom" role="contentinfo"> <div class="container mt-0"> Â© Copyright 2025 Chang Jie Mick Lee, Ph.D. Powered by <a href="https://jekyllrb.com/" target="_blank" rel="external nofollow noopener">Jekyll</a> with <a href="https://github.com/alshedivat/al-folio" rel="external nofollow noopener" target="_blank">al-folio</a> theme. Hosted by <a href="https://pages.github.com/" target="_blank" rel="external nofollow noopener">GitHub Pages</a>. Last updated: May 25, 2025. </div> </footer> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.0/dist/jquery.min.js" integrity="sha256-/xUj+3OJU5yExlq6GSYGSHk7tPXikynS7ogEvDej/m4=" crossorigin="anonymous"></script> <script src="/assets/js/bootstrap.bundle.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/mdbootstrap@4.20.0/js/mdb.min.js" integrity="sha256-NdbiivsvWt7VYCt6hYNT3h/th9vSTL4EDWeGs5SN3DA=" crossorigin="anonymous"></script> <script defer src="https://cdn.jsdelivr.net/npm/masonry-layout@4.2.2/dist/masonry.pkgd.min.js" integrity="sha256-Nn1q/fx0H7SNLZMQ5Hw5JLaTRZp0yILA/FRexe19VdI=" crossorigin="anonymous"></script> <script defer src="https://cdn.jsdelivr.net/npm/imagesloaded@5.0.0/imagesloaded.pkgd.min.js" integrity="sha256-htrLFfZJ6v5udOG+3kNLINIKh2gvoKqwEhHYfTTMICc=" crossorigin="anonymous"></script> <script defer src="/assets/js/masonry.js" type="text/javascript"></script> <script defer src="https://cdn.jsdelivr.net/npm/medium-zoom@1.1.0/dist/medium-zoom.min.js" integrity="sha256-ZgMyDAIYDYGxbcpJcfUnYwNevG/xi9OHKaR/8GK+jWc=" crossorigin="anonymous"></script> <script defer src="/assets/js/zoom.js?85ddb88934d28b74e78031fd54cf8308"></script> <script src="/assets/js/no_defer.js?2930004b8d7fcd0a8e00fdcfc8fc9f24"></script> <script defer src="/assets/js/common.js?4a129fbf39254905f505c7246e641eaf"></script> <script defer src="/assets/js/copy_code.js?12775fdf7f95e901d7119054556e495f" type="text/javascript"></script> <script async src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script async src="https://badge.dimensions.ai/badge.js"></script> <script type="text/javascript">window.MathJax={tex:{tags:"ams"}};</script> <script defer type="text/javascript" id="MathJax-script" src="https://cdn.jsdelivr.net/npm/mathjax@3.2.0/es5/tex-mml-chtml.js"></script> <script defer src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script> <script type="text/javascript">function progressBarSetup(){"max"in document.createElement("progress")?(initializeProgressElement(),$(document).on("scroll",function(){progressBar.attr({value:getCurrentScrollPosition()})}),$(window).on("resize",initializeProgressElement)):(resizeProgressBar(),$(document).on("scroll",resizeProgressBar),$(window).on("resize",resizeProgressBar))}function getCurrentScrollPosition(){return $(window).scrollTop()}function initializeProgressElement(){let e=$("#navbar").outerHeight(!0);$("body").css({"padding-top":e}),$("progress-container").css({"padding-top":e}),progressBar.css({top:e}),progressBar.attr({max:getDistanceToScroll(),value:getCurrentScrollPosition()})}function getDistanceToScroll(){return $(document).height()-$(window).height()}function resizeProgressBar(){progressBar.css({width:getWidthPercentage()+"%"})}function getWidthPercentage(){return getCurrentScrollPosition()/getDistanceToScroll()*100}const progressBar=$("#progress");window.onload=function(){setTimeout(progressBarSetup,50)};</script> </body> </html>